Product Details
Cipro
Ciprofloxacin500 mg
Tablet
DIN/PIN/NPN
02155966
Manufacturer
Bayer Inc., Consumer Care Division
Formulary Listing Date
1996-10-01
Unit Price
NA
Amount MOH Pays
NA
Coverage Status
Not a Benefit
ODB Formulary Therapeutic Classification
Therapeutic Note
Ciprofloxacin: Ciprofloxacin is not intended for the treatment of asymptomatic bacteriuria in the absence of risk factors. Avoid use in pregnancy and children <18 years of age. Ciprofloxacin inhibits theophylline clearance and also affects phenytoin kinetics. Theophylline doses should be decreased and blood levels of phenytoin or theophylline monitored when either of these drugs is used concomitantly with ciprofloxacin.
ATC Code
J01MA02
Interchangeable Products
| DIN/ PIN/ NPN | Brand name | Unit Price | Amount MOH pays |
|---|---|---|---|
| 02379635 | Septa-Ciprofloxacin | 0.5025 | 0.5025 |
| 02248757 | Sandoz Ciprofloxacin | 0.5025 | 0.5025 |
| 02246826 | Ratio-Ciprofloxacin | 0.5025 | 0.5025 |
| 02303736 | Ran-Ciproflox | 0.5025 | 0.5025 |
| 02248438 | PMS-Ciprofloxacin | 0.5025 | 0.5025 |
| 02492008 | NRA-Ciprofloxacin | 0.5025 | 0.5025 |
| 02423561 | Mint-Ciproflox | 0.5025 | 0.5025 |
| 02379694 | Mar-Ciprofloxacin | 0.5025 | 0.5025 |
| 02380366 | Jamp-Ciprofloxacin | 0.5025 | 0.5025 |
| 02247340 | Co Ciprofloxacin | 0.5025 | 0.5025 |
| 02386127 | Ciprofloxacin | 0.5025 | 0.5025 |
| 02353326 | Ciprofloxacin | 0.5025 | 0.5025 |
| 02155966 | Cipro | NA | NA |
| 02381923 | Auro-Ciprofloxacin | 0.5025 | 0.5025 |
| 02229522 | Apo-Ciproflox | 0.5025 | 0.5025 |